LncRNA OIP5-AS1 facilitates gastric cancer cell growth by targeting the miR-422a/ANO1 axis.

OPA-interacting protein 5 antisense transcript 1 (OIP5-AS1) plays an important regulatory role in various types of cancers. However, the functional role and regulatory mechanisms of OIP5-AS1 in gastric cancer (GC) remain largely unknown. In this study, we found that the expression of OIP5-AS1 was increased in GC tissues compared with that in adjacent non-cancerous tissues, which was significantly associated with shorter overall survival time of patients. In addition, OIP5-AS1 expression was also increased in GC cell lines including NCI-N87, MKN-45, BGC-823 and SGC-7901, when compared with that in normal gastric epithelial cell line GES-1. Knockdown of OIP5-AS1 markedly suppressed the proliferation and colony formation activities of GC cells, induced G0/G1 arrest and apoptosis of GC cells in vitro, and restrained tumor growth in vivo. Mechanistically, OIP5-AS1 functions as an oncogenic competing endogenous RNA by binding to and sequestering miR-422a to elevate the expression of anoctamin-1. Our study first demonstrated that OIP5-AS1 is a critical and powerful regulator of GC pathogenesis and may represent a novel candidate target for GC therapy.

[1]  Ying Xu,et al.  LINC01303 functions as a competing endogenous RNA to regulate EZH2 expression by sponging miR‐101‐3p in gastric cancer , 2019, Journal of cellular and molecular medicine.

[2]  Hao-Ran Wu,et al.  Transcriptional activation of ANO1 promotes gastric cancer progression. , 2019, Biochemical and biophysical research communications.

[3]  Jun Yu,et al.  PKNOX2 suppresses gastric cancer through the transcriptional activation of IGFBP5 and p53 , 2019, Oncogene.

[4]  Yibin Kang,et al.  Long Noncoding RNA GMAN, Up-regulated in Gastric Cancer Tissues, Is Associated With Metastasis in Patients and Promotes Translation of Ephrin A1 by Competitively Binding GMAN-AS. , 2019, Gastroenterology.

[5]  Shou-Jiang Gao,et al.  Oncogenic KSHV-encoded interferon regulatory factor upregulates HMGB2 and CMPK1 expression to promote cell invasion by disrupting a complex lncRNA-OIP5-AS1/miR-218-5p network , 2019, PLoS pathogens.

[6]  Hailong An,et al.  Recent advances in TMEM16A: Structure, function, and disease , 2018, Journal of cellular physiology.

[7]  Yifeng Zhou,et al.  Upregulation of long non-coding RNA RAB1A-2 induces FGF1 expression worsening lung cancer prognosis. , 2018, Cancer letters.

[8]  Yong Xia,et al.  LncRNA OIP5‐AS1 predicts poor prognosis and regulates cell proliferation and apoptosis in bladder cancer , 2018, Journal of cellular biochemistry.

[9]  Hailang Sun,et al.  Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[10]  Ming Zhou,et al.  Downregulation of lncRNA GAS5 confers tamoxifen resistance by activating miR-222 in breast cancer. , 2018, Cancer letters.

[11]  Peifeng Li,et al.  The Long Noncoding RNA D63785 Regulates Chemotherapy Sensitivity in Human Gastric Cancer by Targeting miR-422a , 2018, Molecular therapy. Nucleic acids.

[12]  G. Hu,et al.  LncRNA OIP5-AS1 regulates radioresistance by targeting DYRK1A through miR-369-3p in colorectal cancer cells. , 2018, European journal of cell biology.

[13]  Zheng Li,et al.  MiR-422a regulates cellular metabolism and malignancy by targeting pyruvate dehydrogenase kinase 2 in gastric cancer , 2018, Cell Death & Disease.

[14]  F. Liu,et al.  Kockdown of OIP5-AS1 expression inhibits proliferation, metastasis and EMT progress in hepatoblastoma cells through up-regulating miR-186a-5p and down-regulating ZEB1. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[15]  Zhaofeng Chen,et al.  Molecular mechanisms of lncRNA SMARCC2/miR-551b-3p/TMPRSS4 axis in gastric cancer. , 2018, Cancer letters.

[16]  LuGuohao,et al.  Inhibition of STAT6/Anoctamin-1 Activation Suppresses Proliferation and Invasion of Gastric Cancer Cells. , 2018 .

[17]  Chunfeng Liu,et al.  Long non-coding RNA OIP5-AS1 functions as an oncogene in lung adenocarcinoma through targeting miR-448/Bcl-2. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  Meilin Wang,et al.  Hypermethylation of EIF4E promoter is associated with early onset of gastric cancer , 2018, Carcinogenesis.

[19]  Ping Wang,et al.  PIWIL3/OIP5-AS1/miR-367-3p/CEBPA feedback loop regulates the biological behavior of glioma cells , 2018, Theranostics.

[20]  Y. Kotake,et al.  The Long Noncoding RNA OIP5-AS1 Is Involved in the Regulation of Cell Proliferation. , 2018, Anticancer Research.

[21]  Huan Yao,et al.  LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma , 2017, Cell Death & Disease.

[22]  Xunbo Jin,et al.  LncRNA CCAT1 inhibits cell apoptosis of renal cell carcinoma through up-regulation of Livin protein , 2017, Molecular and Cellular Biochemistry.

[23]  S. Zhuang,et al.  HOTAIR functions as a competing endogenous RNA to regulate PTEN expression by inhibiting miR-19 in cardiac hypertrophy , 2017, Molecular and Cellular Biochemistry.

[24]  Wenhui Zhang,et al.  MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression , 2017, Journal of experimental & clinical cancer research : CR.

[25]  Kotb Abdelmohsen,et al.  LncRNA OIP5-AS1/cyrano sponges RNA-binding protein HuR , 2016, Nucleic acids research.

[26]  Z. Lu,et al.  Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b , 2015, Oncogene.

[27]  Y. Toiyama,et al.  Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients. , 2015, Carcinogenesis.

[28]  Jun Liu,et al.  MicroRNA-144 inhibits the metastasis of gastric cancer by targeting MET expression , 2015, Journal of experimental & clinical cancer research : CR.